tirzepatide fda approval has been approved by the for Zepbound (tirzepatide) injection, first and only obesity New Trial Results Position Mounjaro

The drug officially hit the market in December

Experience the difference that physician-guided, personalized care can make on your journey toward better overall health!

You can safely consume the product until the Best Before date displayed on the back of the packaging

Clinical and dermoscopic changes of acquired melanocytic nevi of patients treated with afamelanotide

Borensztein is triple board-certified, with years of experience practicing endocrinology and obesity medicine

It is studied in research into body weight regulation, fat metabolism, appetite regulation and glucose metabolism, thanks to its combined activity at the GLP-1, GIP and glucagon receptor